TABLE 4.
Treatment adherence.
Characteristic | Answer | Percentage | N |
---|---|---|---|
Treatments adherence a | Vedolizumab | 95.1% | 283 |
Elimination diet | 95.0% | 140 | |
Ustekinumab | 94.4% | 392 | |
Infliximab | 92.7% | 993 | |
Steroids | 91.2% | 1116 | |
Adalimumab | 91.1% | 1039 | |
MTX | 91.1% | 259 | |
Vitamins & supplements | 90.0% | 560 | |
Dairy reduction or elimination | 89.9% | 148 | |
Thiopurines | 89.8% | 923 | |
Antibiotics | 88.5% | 157 | |
Gluten‐free diet | 88.4% | 147 | |
5‐Aminosalicylates | 86.9% | 927 | |
Dietary changes (unspecified) | 85.1% | 348 |
Most‐reported treatments with over 50 reports, ranked by highest percentage adherence.